Veterinary Medicines

Gletvax 6, Injekční suspenze

Authorised
  • Escherichia coli, fimbrial adhesin F4ab
  • Escherichia coli, fimbrial adhesin F4ac
  • Escherichia coli, fimbrial adhesin F5
  • Escherichia coli, fimbrial adhesin F6
  • Clostridium perfringens, type B and C, beta toxoid
  • Clostridium perfringens, type D, epsilon toxoid
Download as PDF

Product identification

Medicine name:
Gletvax 6, Injekční suspenze
Active substance:
  • Escherichia coli, fimbrial adhesin F4ab
  • Escherichia coli, fimbrial adhesin F4ac
  • Escherichia coli, fimbrial adhesin F5
  • Escherichia coli, fimbrial adhesin F6
  • Clostridium perfringens, type B and C, beta toxoid
  • Clostridium perfringens, type D, epsilon toxoid
Target species:
  • Pig
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Escherichia coli, fimbrial adhesin F4ab
    14.60
    log2 serum neutralising unit(s)
    /
    1.00
    Dose
  • Escherichia coli, fimbrial adhesin F4ac
    15.50
    log2 serum neutralising unit(s)
    /
    1.00
    Dose
  • Escherichia coli, fimbrial adhesin F5
    12.20
    log2 serum neutralising unit(s)
    /
    1.00
    Dose
  • Escherichia coli, fimbrial adhesin F6
    13.10
    log2 serum neutralising unit(s)
    /
    1.00
    Dose
  • Clostridium perfringens, type B and C, beta toxoid
    300.00
    international unit(s)
    /
    1.00
    Dose
  • Clostridium perfringens, type D, epsilon toxoid
    200.00
    international unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Pig
      • Meat
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB08
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Ceska Republika s.r.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicines
Authorisation number:
  • 97/049/00-C
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."